Dataset Information

Severe Phenotype in Patients with Large Deletions of NF1.

ABSTRACT: Complete deletion of the NF1 gene is identified in 5-10% of patients with neurofibromatosis type 1 (NF1). Several studies have previously described particularly severe forms of the disease in NF1 patients with deletion of the NF1 locus, but comprehensive descriptions of large cohorts are still missing to fully characterize this contiguous gene syndrome. NF1-deleted patients were enrolled and phenotypically characterized with a standardized questionnaire between 2005 and 2020 from a large French NF1 cohort. Statistical analyses for main NF1-associated symptoms were performed versus an NF1 reference population. A deletion of the NF1 gene was detected in 4% (139/3479) of molecularly confirmed NF1 index cases. The median age of the group at clinical investigations was 21 years old. A comprehensive clinical assessment showed that 93% (116/126) of NF1-deleted patients fulfilled the NIH criteria for NF1. More than half had café-au-lait spots, skinfold freckling, Lisch nodules, neurofibromas, neurological abnormalities, and cognitive impairment or learning disabilities. Comparison with previously described "classic" NF1 cohorts showed a significantly higher proportion of symptomatic spinal neurofibromas, dysmorphism, learning disabilities, malignancies, and skeletal and cardiovascular abnormalities in the NF1-deleted group. We described the largest NF1-deleted cohort to date and clarified the more severe phenotype observed in these patients.

SUBMITTER: Pacot L

PROVIDER: S-EPMC8231977 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Severe Phenotype in Patients with Large Deletions of NF1.

Pacot Laurence L Vidaud Dominique D Sabbagh Audrey A Laurendeau Ingrid I Briand-Suleau Audrey A Coustier Audrey A Maillard Théodora T Barbance Cécile C Morice-Picard Fanny F Sigaudy Sabine S Glazunova Olga O OO Damaj Lena L Layet Valérie V Quelin Chloé C Gilbert-Dussardier Brigitte B Audic Frédérique F Dollfus Hélène H Guerrot Anne-Marie AM Lespinasse James J Julia Sophie S Vantyghem Marie-Christine MC Drouard Magali M Lackmy Marilyn M Leheup Bruno B Alembik Yves Y Lemaire Alexia A Nitschké Patrick P Petit Florence F Dieux Coeslier Anne A Mutez Eugénie E Taieb Alain A Fradin Mélanie M Capri Yline Y Nasser Hala H Ruaud Lyse L Dauriat Benjamin B Bourthoumieu Sylvie S Geneviève David D Audebert-Bellanger Séverine S Nizon Mathilde M Stoeva Radka R Hickman Geoffroy G Nicolas Gaël G Mazereeuw-Hautier Juliette J Jannic Arnaud A Ferkal Salah S Parfait Béatrice B Vidaud Michel M Members Of The Nf France Network Wolkenstein Pierre P Pasmant Eric E

Cancers 20210613 12

Complete deletion of the NF1 gene is identified in 5-10% of patients with neurofibromatosis type 1 (NF1). Several studies have previously described particularly severe forms of the disease in NF1 patients with deletion of the NF1 locus, but comprehensive descriptions of large cohorts are still missing to fully characterize this contiguous gene syndrome. NF1-deleted patients were enrolled and phenotypically characterized with a standardized questionnaire between 2005 and 2020 ...[more]

PMID: 34199217

Similar Datasets

Project description:Neurofibromatosis type-1 (NF1) patients suffer from cutaneous and subcutaneous neurofibromas (CNF) and large plexiform neurofibromas (PNF). Whole gene deletions of the NF1 gene can cause a more severe phenotype compared to smaller intragenic changes. Two distinct groups of NF1 whole gene deletions are type-1 deletions and atypical deletions. Our aim was to assess volumes and averaged annual growth-rates of CNF and PNF in patients with NF1 whole gene deletions and to compare these with NF1 patients without large deletions of the NF1 gene. We retrospectively evaluated 140 whole-body MR examinations of 38 patients with NF1 whole gene deletions (type-1 group: n = 27/atypical group n = 11) and an age- and sex matched collective of 38 NF1-patients. Age-dependent subgroups were created (0-18 vs >18 years). Sixty-four patients received follow-up MRI examinations (NF1whole gene deletion n = 32/control group n = 32). Whole-body tumor-volumes were semi-automatically assessed (MedX, V3.42). Tumor volumes and averaged annual growth-rates were compared. Median tumor-burden was significantly higher in the type-1 group (418ml; IQR 77 - 950ml, p = 0.012) but not in the atypical group (356ml;IQR 140-1190ml, p = 0.099) when compared to the controls (49ml; IQR 11-691ml). Averaged annual growth rates were significantly higher in both the type-1 group (14%/year; IQR 45-36%/year, p = 0.004) and atypical group (11%/year; IQR 5-23%/year, p = 0.014) compared to the controls (4%/year; IQR1-8%/year). Averaged annual growth rates were significantly higher in pediatric patients with type-1 deletions (21%/year) compared with adult patients (8%/year, p = 0.014) and also compared with pediatric patients without large deletions of the NF1 gene (3.3%/year, p = 0.0015). NF1 whole gene deletions cause a more severe phenotype of NF1 with higher tumor burden and higher growth-rates compared to NF1 patients without large deletions of the NF1 gene. In particular, pediatric patients with type-1 deletions display a pronounced tumor growth.

Dataset Information

Severe Phenotype in Patients with Large Deletions of NF1.

Publications

Severe Phenotype in Patients with Large Deletions of <i>NF1</i>.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets